Industry Research Reports

Home > Reports > Food & Beverages > Glucokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Glucokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Food & Beverages

Published Date: 2025-02-27

Pages: 109 Pages

Report ld: 4344784

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Glucokinase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Glucokinase was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Glucokinase was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Glucokinase was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Glucokinase include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc, Yuhan Corp, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Glucokinase, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Glucokinase by region & country, by Type, and by Application.

The Glucokinase market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucokinase.

MARKET SEGMENTATION

By Company

Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

LY-2608204
Sinogliatin
AM-9514
TMG-123
TTP-399
Others

Segment by Application

Metabolic Disorder
Obesity
Diabetes
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Glucokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Glucokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Glucokinase in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Glucokinase Product Introduction

1.2 Global Glucokinase Market Size Forecast

1.2.1 Global Glucokinase Sales Value (2020-2031)

1.2.2 Global Glucokinase Sales Volume (2020-2031)

1.2.3 Global Glucokinase Sales Price (2020-2031)

1.3 Glucokinase Market Trends & Drivers

1.3.1 Glucokinase Industry Trends

1.3.2 Glucokinase Market Drivers & Opportunity

1.3.3 Glucokinase Market Challenges

1.3.4 Glucokinase Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Glucokinase Players Revenue Ranking (2024)

2.2 Global Glucokinase Revenue by Company (2020-2025)

2.3 Global Glucokinase Players Sales Volume Ranking (2024)

2.4 Global Glucokinase Sales Volume by Company Players (2020-2025)

2.5 Global Glucokinase Average Price by Company (2020-2025)

2.6 Key Manufacturers Glucokinase Manufacturing Base and Headquarters

2.7 Key Manufacturers Glucokinase Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Glucokinase

2.9 Glucokinase Market Competitive Analysis

2.9.1 Glucokinase Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Glucokinase Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucokinase as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 LY-2608204

3.1.2 Sinogliatin

3.1.3 AM-9514

3.1.4 TMG-123

3.1.5 TTP-399

3.1.6 Others

3.2 Global Glucokinase Sales Value by Type

3.2.1 Global Glucokinase Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Glucokinase Sales Value, by Type (2020-2031)

3.2.3 Global Glucokinase Sales Value, by Type (%) (2020-2031)

3.3 Global Glucokinase Sales Volume by Type

3.3.1 Global Glucokinase Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Glucokinase Sales Volume, by Type (2020-2031)

3.3.3 Global Glucokinase Sales Volume, by Type (%) (2020-2031)

3.4 Global Glucokinase Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Metabolic Disorder

4.1.2 Obesity

4.1.3 Diabetes

4.1.4 Others

4.2 Global Glucokinase Sales Value by Application

4.2.1 Global Glucokinase Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Glucokinase Sales Value, by Application (2020-2031)

4.2.3 Global Glucokinase Sales Value, by Application (%) (2020-2031)

4.3 Global Glucokinase Sales Volume by Application

4.3.1 Global Glucokinase Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Glucokinase Sales Volume, by Application (2020-2031)

4.3.3 Global Glucokinase Sales Volume, by Application (%) (2020-2031)

4.4 Global Glucokinase Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Glucokinase Sales Value by Region

5.1.1 Global Glucokinase Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Glucokinase Sales Value by Region (2020-2025)

5.1.3 Global Glucokinase Sales Value by Region (2026-2031)

5.1.4 Global Glucokinase Sales Value by Region (%), (2020-2031)

5.2 Global Glucokinase Sales Volume by Region

5.2.1 Global Glucokinase Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Glucokinase Sales Volume by Region (2020-2025)

5.2.3 Global Glucokinase Sales Volume by Region (2026-2031)

5.2.4 Global Glucokinase Sales Volume by Region (%), (2020-2031)

5.3 Global Glucokinase Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Glucokinase Sales Value, 2020-2031

5.4.2 North America Glucokinase Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Glucokinase Sales Value, 2020-2031

5.5.2 Europe Glucokinase Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Glucokinase Sales Value, 2020-2031

5.6.2 Asia Pacific Glucokinase Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Glucokinase Sales Value, 2020-2031

5.7.2 South America Glucokinase Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Glucokinase Sales Value, 2020-2031

5.8.2 Middle East & Africa Glucokinase Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Glucokinase Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Glucokinase Sales Value

6.2.1 Key Countries/Regions Glucokinase Sales Value, 2020-2031

6.2.2 Key Countries/Regions Glucokinase Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Glucokinase Sales Value, 2020-2031

6.3.2 United States Glucokinase Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Glucokinase Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Glucokinase Sales Value, 2020-2031

6.4.2 Europe Glucokinase Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Glucokinase Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Glucokinase Sales Value, 2020-2031

6.5.2 China Glucokinase Sales Value by Type (%), 2024 VS 2031

6.5.3 China Glucokinase Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Glucokinase Sales Value, 2020-2031

6.6.2 Japan Glucokinase Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Glucokinase Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Glucokinase Sales Value, 2020-2031

6.7.2 South Korea Glucokinase Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Glucokinase Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Glucokinase Sales Value, 2020-2031

6.8.2 Southeast Asia Glucokinase Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Glucokinase Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Glucokinase Sales Value, 2020-2031

6.9.2 India Glucokinase Sales Value by Type (%), 2024 VS 2031

6.9.3 India Glucokinase Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Amgen Inc

7.1.1 Amgen Inc Company Information

7.1.2 Amgen Inc Introduction and Business Overview

7.1.3 Amgen Inc Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Amgen Inc Glucokinase Product Offerings

7.1.5 Amgen Inc Recent Development

7.2 Eli Lilly and Co

7.2.1 Eli Lilly and Co Company Information

7.2.2 Eli Lilly and Co Introduction and Business Overview

7.2.3 Eli Lilly and Co Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Eli Lilly and Co Glucokinase Product Offerings

7.2.5 Eli Lilly and Co Recent Development

7.3 Ligand Pharmaceuticals Inc

7.3.1 Ligand Pharmaceuticals Inc Company Information

7.3.2 Ligand Pharmaceuticals Inc Introduction and Business Overview

7.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Offerings

7.3.5 Ligand Pharmaceuticals Inc Recent Development

7.4 Merck & Co Inc

7.4.1 Merck & Co Inc Company Information

7.4.2 Merck & Co Inc Introduction and Business Overview

7.4.3 Merck & Co Inc Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Merck & Co Inc Glucokinase Product Offerings

7.4.5 Merck & Co Inc Recent Development

7.5 Poxel SA

7.5.1 Poxel SA Company Information

7.5.2 Poxel SA Introduction and Business Overview

7.5.3 Poxel SA Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Poxel SA Glucokinase Product Offerings

7.5.5 Poxel SA Recent Development

7.6 Teijin Pharma Ltd

7.6.1 Teijin Pharma Ltd Company Information

7.6.2 Teijin Pharma Ltd Introduction and Business Overview

7.6.3 Teijin Pharma Ltd Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Teijin Pharma Ltd Glucokinase Product Offerings

7.6.5 Teijin Pharma Ltd Recent Development

7.7 vTv Therapeutics Inc

7.7.1 vTv Therapeutics Inc Company Information

7.7.2 vTv Therapeutics Inc Introduction and Business Overview

7.7.3 vTv Therapeutics Inc Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 vTv Therapeutics Inc Glucokinase Product Offerings

7.7.5 vTv Therapeutics Inc Recent Development

7.8 Yuhan Corp

7.8.1 Yuhan Corp Company Information

7.8.2 Yuhan Corp Introduction and Business Overview

7.8.3 Yuhan Corp Glucokinase Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Yuhan Corp Glucokinase Product Offerings

7.8.5 Yuhan Corp Recent Development

8 Industry Chain Analysis

8.1 Glucokinase Industrial Chain

8.2 Glucokinase Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Glucokinase Sales Model

8.5.2 Sales Channel

8.5.3 Glucokinase Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Glucokinase Market Trends

Table 2. Glucokinase Market Drivers & Opportunity

Table 3. Glucokinase Market Challenges

Table 4. Glucokinase Market Restraints

Table 5. Global Glucokinase Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Glucokinase Revenue Market Share by Company (2020-2025)

Table 7. Global Glucokinase Sales Volume by Company (2020-2025) & (K Pcs)

Table 8. Global Glucokinase Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Glucokinase Price by Company (2020-2025) & (USD/Pcs)

Table 10. Key Manufacturers Glucokinase Manufacturing Base and Headquarters

Table 11. Key Manufacturers Glucokinase Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Glucokinase

Table 13. Global Glucokinase Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucokinase as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Glucokinase Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Glucokinase Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Glucokinase Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Glucokinase Sales Market Share in Value by Type (2020-2025)

Table 20. Global Glucokinase Sales Market Share in Value by Type (2026-2031)

Table 21. Global Glucokinase Sales Volume by Type: 2020 VS 2024 VS 2031 (K Pcs)

Table 22. Global Glucokinase Sales Volume by Type (2020-2025) & (K Pcs)

Table 23. Global Glucokinase Sales Volume by Type (2026-2031) & (K Pcs)

Table 24. Global Glucokinase Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Glucokinase Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Glucokinase Price by Type (2020-2025) & (USD/Pcs)

Table 27. Global Glucokinase Price by Type (2026-2031) & (USD/Pcs)

Table 28. Global Glucokinase Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Glucokinase Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Glucokinase Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Glucokinase Sales Market Share in Value by Application (2020-2025)

Table 32. Global Glucokinase Sales Market Share in Value by Application (2026-2031)

Table 33. Global Glucokinase Sales Volume by Application: 2020 VS 2024 VS 2031 (K Pcs)

Table 34. Global Glucokinase Sales Volume by Application (2020-2025) & (K Pcs)

Table 35. Global Glucokinase Sales Volume by Application (2026-2031) & (K Pcs)

Table 36. Global Glucokinase Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Glucokinase Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Glucokinase Price by Application (2020-2025) & (USD/Pcs)

Table 39. Global Glucokinase Price by Application (2026-2031) & (USD/Pcs)

Table 40. Global Glucokinase Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Glucokinase Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Glucokinase Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Glucokinase Sales Value by Region (2020-2025) & (%)

Table 44. Global Glucokinase Sales Value by Region (2026-2031) & (%)

Table 45. Global Glucokinase Sales Volume by Region (K Pcs): 2020 VS 2024 VS 2031

Table 46. Global Glucokinase Sales Volume by Region (2020-2025) & (K Pcs)

Table 47. Global Glucokinase Sales Volume by Region (2026-2031) & (K Pcs)

Table 48. Global Glucokinase Sales Volume by Region (2020-2025) & (%)

Table 49. Global Glucokinase Sales Volume by Region (2026-2031) & (%)

Table 50. Global Glucokinase Average Price by Region (2020-2025) & (USD/Pcs)

Table 51. Global Glucokinase Average Price by Region (2026-2031) & (USD/Pcs)

Table 52. Key Countries/Regions Glucokinase Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Glucokinase Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Glucokinase Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Glucokinase Sales Volume, (2020-2025) & (K Pcs)

Table 56. Key Countries/Regions Glucokinase Sales Volume, (2026-2031) & (K Pcs)

Table 57. Amgen Inc Company Information

Table 58. Amgen Inc Introduction and Business Overview

Table 59. Amgen Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 60. Amgen Inc Glucokinase Product Offerings

Table 61. Amgen Inc Recent Development

Table 62. Eli Lilly and Co Company Information

Table 63. Eli Lilly and Co Introduction and Business Overview

Table 64. Eli Lilly and Co Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 65. Eli Lilly and Co Glucokinase Product Offerings

Table 66. Eli Lilly and Co Recent Development

Table 67. Ligand Pharmaceuticals Inc Company Information

Table 68. Ligand Pharmaceuticals Inc Introduction and Business Overview

Table 69. Ligand Pharmaceuticals Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 70. Ligand Pharmaceuticals Inc Glucokinase Product Offerings

Table 71. Ligand Pharmaceuticals Inc Recent Development

Table 72. Merck & Co Inc Company Information

Table 73. Merck & Co Inc Introduction and Business Overview

Table 74. Merck & Co Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 75. Merck & Co Inc Glucokinase Product Offerings

Table 76. Merck & Co Inc Recent Development

Table 77. Poxel SA Company Information

Table 78. Poxel SA Introduction and Business Overview

Table 79. Poxel SA Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 80. Poxel SA Glucokinase Product Offerings

Table 81. Poxel SA Recent Development

Table 82. Teijin Pharma Ltd Company Information

Table 83. Teijin Pharma Ltd Introduction and Business Overview

Table 84. Teijin Pharma Ltd Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 85. Teijin Pharma Ltd Glucokinase Product Offerings

Table 86. Teijin Pharma Ltd Recent Development

Table 87. vTv Therapeutics Inc Company Information

Table 88. vTv Therapeutics Inc Introduction and Business Overview

Table 89. vTv Therapeutics Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 90. vTv Therapeutics Inc Glucokinase Product Offerings

Table 91. vTv Therapeutics Inc Recent Development

Table 92. Yuhan Corp Company Information

Table 93. Yuhan Corp Introduction and Business Overview

Table 94. Yuhan Corp Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 95. Yuhan Corp Glucokinase Product Offerings

Table 96. Yuhan Corp Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Glucokinase Downstream Customers

Table 100. Glucokinase Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Glucokinase Product Picture

Figure 2. Global Glucokinase Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Glucokinase Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Glucokinase Sales Volume (2020-2031) & (K Pcs)

Figure 5. Global Glucokinase Sales Price (2020-2031) & (USD/Pcs)

Figure 6. Glucokinase Report Years Considered

Figure 7. Global Glucokinase Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Glucokinase Players Sales Volume Ranking (2024) & (K Pcs)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucokinase Revenue in 2024

Figure 10. Glucokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. LY-2608204 Picture

Figure 12. Sinogliatin Picture

Figure 13. AM-9514 Picture

Figure 14. TMG-123 Picture

Figure 15. TTP-399 Picture

Figure 16. Others Picture

Figure 17. Global Glucokinase Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 18. Global Glucokinase Sales Value Market Share by Type, 2024 & 2031

Figure 19. Global Glucokinase Sales Volume by Type (2020 VS 2024 VS 2031) & (K Pcs)

Figure 20. Global Glucokinase Sales Volume Market Share by Type, 2024 & 2031

Figure 21. Global Glucokinase Price by Type (2020-2031) & (USD/Pcs)

Figure 22. Product Picture of Metabolic Disorder

Figure 23. Product Picture of Obesity

Figure 24. Product Picture of Diabetes

Figure 25. Product Picture of Others

Figure 26. Global Glucokinase Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 27. Global Glucokinase Sales Value Market Share by Application, 2024 & 2031

Figure 28. Global Glucokinase Sales Volume by Application (2020 VS 2024 VS 2031) & (K Pcs)

Figure 29. Global Glucokinase Sales Volume Market Share by Application, 2024 & 2031

Figure 30. Global Glucokinase Price by Application (2020-2031) & (USD/Pcs)

Figure 31. North America Glucokinase Sales Value (2020-2031) & (US$ Million)

Figure 32. North America Glucokinase Sales Value by Country (%), 2024 VS 2031

Figure 33. Europe Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 34. Europe Glucokinase Sales Value by Country (%), 2024 VS 2031

Figure 35. Asia Pacific Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Glucokinase Sales Value by Region (%), 2024 VS 2031

Figure 37. South America Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 38. South America Glucokinase Sales Value by Country (%), 2024 VS 2031

Figure 39. Middle East & Africa Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 40. Middle East & Africa Glucokinase Sales Value by Country (%), 2024 VS 2031

Figure 41. Key Countries/Regions Glucokinase Sales Value (%), (2020-2031)

Figure 42. Key Countries/Regions Glucokinase Sales Volume (%), (2020-2031)

Figure 43. United States Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 44. United States Glucokinase Sales Value by Type (%), 2024 VS 2031

Figure 45. United States Glucokinase Sales Value by Application (%), 2024 VS 2031

Figure 46. Europe Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 47. Europe Glucokinase Sales Value by Type (%), 2024 VS 2031

Figure 48. Europe Glucokinase Sales Value by Application (%), 2024 VS 2031

Figure 49. China Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 50. China Glucokinase Sales Value by Type (%), 2024 VS 2031

Figure 51. China Glucokinase Sales Value by Application (%), 2024 VS 2031

Figure 52. Japan Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 53. Japan Glucokinase Sales Value by Type (%), 2024 VS 2031

Figure 54. Japan Glucokinase Sales Value by Application (%), 2024 VS 2031

Figure 55. South Korea Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 56. South Korea Glucokinase Sales Value by Type (%), 2024 VS 2031

Figure 57. South Korea Glucokinase Sales Value by Application (%), 2024 VS 2031

Figure 58. Southeast Asia Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 59. Southeast Asia Glucokinase Sales Value by Type (%), 2024 VS 2031

Figure 60. Southeast Asia Glucokinase Sales Value by Application (%), 2024 VS 2031

Figure 61. India Glucokinase Sales Value, (2020-2031) & (US$ Million)

Figure 62. India Glucokinase Sales Value by Type (%), 2024 VS 2031

Figure 63. India Glucokinase Sales Value by Application (%), 2024 VS 2031

Figure 64. Glucokinase Industrial Chain

Figure 65. Glucokinase Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Glucokinase market? zhanKai

The top companies in the global Glucokinase market are Amgen Inc、Eli Lilly and Co、Ligand Pharmaceuticals Inc.

Related Reports

Glucokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glucokinase was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 126
USD 3950.00
(Single User License)
Global Glucokinase Market Research Report 2026
The global Glucokinase market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 112
USD 2900.00
(Single User License)
Global Glucokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glucokinase market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 77
USD 4250.00
(Single User License)
Global Glucokinase Market Research Report 2025
The global market for Glucokinase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-27
Pages: 79
USD 2900.00
(Single User License)
Global Glucokinase Market Insights, Forecast to 2030
The global Glucokinase market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-26
Pages: 95
USD 4900.00
(Single User License)
Global Glucokinase Market Research Report 2024
The global Glucokinase market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-14
Pages: 85
USD 2900.00
(Single User License)

Glucokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glucokinase was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 126
USD 3950.00 (Single User License)
Global Glucokinase Market Research Report 2026
The global Glucokinase market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 112
USD 2900.00 (Single User License)
Global Glucokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glucokinase market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 77
USD 4250.00 (Single User License)
Global Glucokinase Market Research Report 2025
The global market for Glucokinase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 79
USD 2900.00 (Single User License)
Global Glucokinase Market Insights, Forecast to 2030
The global Glucokinase market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-26
Pages: 95
USD 4900.00 (Single User License)
Global Glucokinase Market Research Report 2024
The global Glucokinase market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-14
Pages: 85
USD 2900.00 (Single User License)